학술논문
PGI16 COST-EFFECTIVENESS OF TOFACITINIB FOR THE TREATMENT OF MODERATE-TO-SEVERE ULCERATIVE COLITIS AFTER BIOLOGIC FAILURE OR INTOLERANCE IN SPAIN
Document Type
Abstract
Author
Source
In Value in Health November 2019 22 Supplement 3:S619-S619
Subject
Language
ISSN
1098-3015